John A. Reynolds

2.5k total citations
78 papers, 1.2k citations indexed

About

John A. Reynolds is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, John A. Reynolds has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Rheumatology, 26 papers in Immunology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in John A. Reynolds's work include Systemic Lupus Erythematosus Research (30 papers), Atherosclerosis and Cardiovascular Diseases (13 papers) and T-cell and B-cell Immunology (9 papers). John A. Reynolds is often cited by papers focused on Systemic Lupus Erythematosus Research (30 papers), Atherosclerosis and Cardiovascular Diseases (13 papers) and T-cell and B-cell Immunology (9 papers). John A. Reynolds collaborates with scholars based in United Kingdom, United States and Italy. John A. Reynolds's co-authors include Ian N Bruce, C. J. Peters, M. Yvonne Alexander, H. A. Blevin, P. C. Thonemann, T. W. Slone, C. L. Crabbs, E. L. Stephen, N. R. Di Luzio and G. H. Scott and has published in prestigious journals such as The Lancet, Physical Review Letters and Applied Physics Letters.

In The Last Decade

John A. Reynolds

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Reynolds United Kingdom 21 331 292 198 173 146 78 1.2k
Stefano Fontana Italy 24 185 0.6× 160 0.5× 112 0.6× 283 1.6× 296 2.0× 97 1.8k
J. M. England United Kingdom 26 271 0.8× 167 0.6× 47 0.2× 63 0.4× 311 2.1× 95 2.1k
Timo Jahnukainen Finland 28 204 0.6× 182 0.6× 114 0.6× 131 0.8× 494 3.4× 123 2.6k
Brian S. Bull United States 33 88 0.3× 187 0.6× 83 0.4× 93 0.5× 306 2.1× 130 4.0k
Antonella Tosoni Italy 22 102 0.3× 101 0.3× 180 0.9× 865 5.0× 337 2.3× 54 2.2k
Edward M. Dwyer United States 31 153 0.5× 347 1.2× 86 0.4× 404 2.3× 149 1.0× 81 3.1k
Hiroyuki Hashimoto Japan 15 50 0.2× 283 1.0× 62 0.3× 117 0.7× 212 1.5× 57 1.2k
Jeffrey M. Harris United States 26 182 0.5× 1.3k 4.6× 87 0.4× 209 1.2× 480 3.3× 64 4.8k
Xiaoping Kang China 19 172 0.5× 79 0.3× 45 0.2× 196 1.1× 198 1.4× 78 1.1k
Rohit Katial United States 29 177 0.5× 706 2.4× 33 0.2× 94 0.5× 126 0.9× 121 3.0k

Countries citing papers authored by John A. Reynolds

Since Specialization
Citations

This map shows the geographic impact of John A. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Reynolds more than expected).

Fields of papers citing papers by John A. Reynolds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Reynolds. The network helps show where John A. Reynolds may publish in the future.

Co-authorship network of co-authors of John A. Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Reynolds. A scholar is included among the top collaborators of John A. Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Reynolds. John A. Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Legge, Alexandra, John A. Reynolds, Manuel F. Ugarte‐Gil, et al.. (2025). Meeting report: The Systemic Lupus International Collaborating Clinics (SLICC) World Lupus Seminar on Africa. Lupus Science & Medicine. 12(1). e001452–e001452.
2.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2024). Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort. Seminars in Arthritis and Rheumatism. 67. 152463–152463. 1 indexed citations
3.
Singh, Megha, Siang Ing Lee, Kelvin Okoth, et al.. (2024). Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. BMC Medicine. 22(1). 94–94. 15 indexed citations
4.
5.
Roberts, Amy L., Philip Tombleson, John A. Reynolds, et al.. (2024). Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 83(10). 1315–1321. 4 indexed citations
6.
Singh, Megha, et al.. (2024). Pregnancy complications and autoimmune diseases in women: systematic review and meta-analysis. BMC Medicine. 22(1). 339–339. 3 indexed citations
7.
Edwards, Christopher J, Michael R. Ehrenstein, Bridget Griffiths, et al.. (2023). Differences in management approaches for lupus nephritis within the UK. Rheumatology Advances in Practice. 8(1). rkae017–rkae017. 3 indexed citations
8.
Roberts, Claudia, et al.. (2023). Insights into the cellular basis of skin inflammation in systemic autoimmune rheumatic diseases from single-cell technologies. Clinical and Experimental Rheumatology. 42(9). 1846–1855. 1 indexed citations
9.
10.
Reynolds, John A., Sian Faustini, Sofia Tosounidou, et al.. (2023). Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE. Lupus. 32(3). 431–437. 1 indexed citations
11.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2022). Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort. Lara D. Veeken. 62(8). 2673–2682. 4 indexed citations
12.
Reynolds, John A., Mary Gayed, Munther A. Khamashta, et al.. (2022). Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine. Lara D. Veeken. 62(3). 1124–1135. 11 indexed citations
13.
Reynolds, John A., et al.. (2021). Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory models. Arthritis Research & Therapy. 23(1). 203–203. 5 indexed citations
14.
Dubey, Shirish, Caroline Gordon, Tom Sheeran, et al.. (2021). Understanding the impact of systemic lupus erythematosus on work amongst South Asian people in the UK: An explorative qualitative study. Lupus. 30(9). 1492–1501. 4 indexed citations
15.
Reynolds, John A., Tracy A. Briggs, Gillian Rice, et al.. (2019). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis Research & Therapy. 21(1). 147–147. 19 indexed citations
16.
Reynolds, John A., David Ray, Leo Zeef, et al.. (2014). The Effect of Type 1 IFN on Human Aortic Endothelial Cell Function In Vitro : Relevance to Systemic Lupus Erythematosus. Journal of Interferon & Cytokine Research. 34(5). 404–412. 10 indexed citations
17.
Reynolds, John A. & Ian N Bruce. (2013). Overview of the management of systemic lupus erythematosus. Renal Failure. 41(2). 1–11. 4 indexed citations
18.
Williamson, Kate, Andrew Hamilton, John A. Reynolds, et al.. (2012). Age‐related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans. Aging Cell. 12(1). 139–147. 48 indexed citations
19.
Reynolds, John A., et al.. (2012). INTERFERON-MEDIATED VASCULAR DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS: FAILURE OF ENDOTHELIAL REPAIR RATHER THAN DIRECT ENDOTHELIAL TOXICITY?. Lara D. Veeken. 51. 181–181. 1 indexed citations
20.
Bodin, H.A.B., et al.. (1962). RAPID AXIAL CONTRACTION OF A HIGH DENSITY DEUTERIUM PLASMA IN A THETATRON DISCHARGE. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 52(5). 732–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Fontana Breakdown of academic impact, for papers by J. M. England Breakdown of academic impact, for papers by Timo Jahnukainen Breakdown of academic impact, for papers by Brian S. Bull Breakdown of academic impact, for papers by Antonella Tosoni Breakdown of academic impact, for papers by Edward M. Dwyer Breakdown of academic impact, for papers by Hiroyuki Hashimoto Breakdown of academic impact, for papers by Jeffrey M. Harris Breakdown of academic impact, for papers by Xiaoping Kang Breakdown of academic impact, for papers by Rohit Katial
Rankless by CCL
2026